Carlsbad, CA – On February 26, 2020, Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia (COVID-19). The full suite of antibodies is now available for research as well as commercial applications. “The discovery and expression of a full human antibody against the COVID-19 virus is […]

Collaboration on Novel iCIEF-MS Platform speeds up critical decisions and streamlines approaches in biopharma environment SCIEX, a global leader in life science analytical technologies, and Intabio, a developer of innovative instrumentation systems for biotherapeutic precision analysis and quality assessment, announced a collaboration to couple Intabio’s Blaze™ system with SCIEX high resolution accurate mass (HRAM) systems. This […]

BOSTON — NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at Harvard University, through an exclusive license agreement with Harvard Office of Technology Development. NanoMosaic’s screening tools may aid in a number of biomedical fields including the early detection of disease, prognostic monitoring, biomarker discovery, and infectious disease […]

Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding […]

Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2 BERGISCH GLADBACH – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide Pools work […]

Robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis SCIEX, a global leader in life science analytical technologies, launched a new method for streamlining and improving the production of gene therapies. This innovative capillary electrophoretic method addresses a key customer challenge by analyzing AAVs to determine whether the therapeutic transgene […]

908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced an expansion of their joint innovation partnership with Transcenta, a fully integrated global biotherapeutics company. The company’s world-class technology center (“Center”) for biotherapeutic process and product development and manufacturing subsidiary, HJB, is located in Hangzhou, China. 908 Devices and Transcenta’s HJB […]

BILLERICA, Mass.– Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed or cancelled due to COVID-19, Bruker […]

Funded by the Bill and Melinda Gates Foundation, CoVIC Seeks to Find Therapeutic Candidates for COVID-19 in Just Weeks SALT LAKE CITY, UTAH and LA JOLLA, CALIFORNIA (March 31, 2020) – Carterra Inc., the world leader in high-throughput antibody screening and characterization tools, and La Jolla Institute for Immunology (LJI), announced today that they will […]

BILLERICA, Mass — Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the following statement amid the continued COVID-19 global crisis, severely impacting public health and the economy. As COVID-19 continues to affect a growing number of people in the U.S. and around the world, Quanterix remains committed to the safety […]